Anti-™2D1 monoclonal antibody

Pre-made anti-™2D1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™2D1/™2D1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1919-Ab-1/ GM-Tg-hg-IP1919-Ab-2Anti-Human ™2D1 monoclonal antibodyHuman
GM-Tg-rg-IP1919-Ab-1/ GM-Tg-rg-IP1919-Ab-2Anti-Rat ™2D1 monoclonal antibodyRat
GM-Tg-mg-IP1919-Ab-1/ GM-Tg-mg-IP1919-Ab-2Anti-Mouse ™2D1 monoclonal antibodyMouse
GM-Tg-cynog-IP1919-Ab-1/ GM-Tg-cynog-IP1919-Ab-2Anti-Cynomolgus/ Rhesus macaque ™2D1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1919-Ab-1/ GM-Tg-felg-IP1919-Ab-2Anti-Feline ™2D1 monoclonal antibodyFeline
GM-Tg-cang-IP1919-Ab-1/ GM-Tg-cang-IP1919-Ab-2Anti-Canine ™2D1 monoclonal antibodyCanine
GM-Tg-bovg-IP1919-Ab-1/ GM-Tg-bovg-IP1919-Ab-2Anti-Bovine ™2D1 monoclonal antibodyBovine
GM-Tg-equg-IP1919-Ab-1/ GM-Tg-equg-IP1919-Ab-2Anti-Equine ™2D1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1919-Ab-1/ GM-Tg-hg-IP1919-Ab-2; GM-Tg-rg-IP1919-Ab-1/ GM-Tg-rg-IP1919-Ab-2;
GM-Tg-mg-IP1919-Ab-1/ GM-Tg-mg-IP1919-Ab-2; GM-Tg-cynog-IP1919-Ab-1/ GM-Tg-cynog-IP1919-Ab-2;
GM-Tg-felg-IP1919-Ab-1/ GM-Tg-felg-IP1919-Ab-2; GM-Tg-cang-IP1919-Ab-1/ GM-Tg-cang-IP1919-Ab-2;
GM-Tg-bovg-IP1919-Ab-1/ GM-Tg-bovg-IP1919-Ab-2; GM-Tg-equg-IP1919-Ab-1/ GM-Tg-equg-IP1919-Ab-2
Products NameAnti-™2D1 monoclonal antibody
Formatmab
Target Name™2D1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™2D1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1919-Ag-1Recombinant multi-species ™2D1/ BBP protein
    ORF Viral VectorvGMLP002530human ™2D1 Lentivirus particle
    ORF Viral VectorpGMLP002530human ™2D1 Lentivirus plasmid
    ORF Viral VectorpGMLPm002412mouse Tm2d1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002412mouse Tm2d1 Lentivirus particle


    Target information

    Target IDGM-IP1919
    Target Name™2D1
    Gene ID83941,94043,362545,694282,479551,101080393,514249,100070493
    Gene Symbol and Synonyms2310026L18Rik,BBP,™2D1
    Uniprot AccessionQ9BX74
    Uniprot Entry Name™2D1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162604
    Target ClassificationN/A

    The target: ™2D1, gene name: ™2D1, also named as BBP. The protein encoded by this gene is a beta-amyloid peptide-binding protein. It contains a structural module related to that of the seven transmembrane domain G protein-coupled receptor superfamily and known to be important in heterotrimeric G protein activation. Beta-amyloid peptide has been established to be a causative factor in neuron death and the consequent diminution of cognitive abilities observed in Alzheimer's disease. This protein may be a target of neurotoxic beta-amyloid peptide, and may mediate cellular vulnerability to beta-amyloid peptide toxicity through a G protein-regulated program of cell death. Several transcript variants have been found for this gene. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.